FDA Adverse Event Injury Summary report: N

IMPLANTABLE COLLAMER LENS (ICL)

MDR report key: 15830521 · Received November 19, 2022

Report

Report Number
2023826-2022-03972
Event Type
Injury
Date Received
November 19, 2022
Date of Event
October 3, 2022
Report Date
October 21, 2022
Manufacturer
STAAR SURGICAL COMPANY
Product Code
QCB
PMA / PMN Number
P030016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CLAIM # (B)(4).

Additional Manufacturer Narrative · 0

CORRECTED DATA: B1: ADVERSE EVENT SHOULD BE CORRECTED TO PRODUCT PROBLEM. B2: OUTCOMES ATTRIBUTED TO ADVERSE EVENT- SHOULD BE OMITTED FOR CORRECTION. D9: DEVICE AVAILABLE FOR EVALUATION: YES; RETURN DATE: 20-DEC-2022. CLAIM#: (B)(4).

Additional Manufacturer Narrative · 0

H3 - DEVICE EVALUATION: THE LENS WAS RETURNED DRY IN A MICROCENTRIFUGE VIAL WITH RESIDUE/DEBRIS ON THE LENS. VISUAL INSPECTION FOUND THE HAPTIC TORN AND BENT WITH FOREIGN MATERIAL ON THE LENS, SPECIFICALLY DEBRIS THROUGHOUT THE LENS. CLAIM# (B)(4).

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: B5: THE REPORTER INDICATED THAT A 12.6MM VTICMO12.6 IMPLANTABLE COLLAMER LENS OF -15.5/1.5/170 (SPHERE/CYLINDER/AXIS) WAS IMPLANTED INTO THE PATIENT'S RIGHT EYE (OD) AS A REPLACEMENT LENS ON (B)(6) 2022. THE LENS WAS EXPLANTED AT AN UNKNOWN DATE. THE PROBLEM WAS NOT RESOLVED FOR THE EXCHANGE. REPORTEDLY, "VISUAL GHOSTING," AND "TAKE OUT THE CRYSTAL." CLAIM# (B)(4).

Description of Event or Problem · 0

THE REPORTER INDICATED THAT A 12.6MM VTICMO12.6 IMPLANTABLE COLLAMER LENS OF -15.5/1.5/170 (SPHERE/CYLINDER/AXIS) WAS IMPLANTED INTO THE PATIENT'S RIGHT EYE (OD) AS A REPLACEMENT LENS ON (B)(6) 2022. THE PROBLEM WAS NOT RESOLVED FOR THE EXCHANGE. REPORTEDLY, "VISUAL GHOSTING," AND "TAKE OUT THE CRYSTAL."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1729869 IMPLANTABLE COLLAMER LENS (ICL) PHAKIC TORIC INTRAOCULAR LENS QCB STAAR SURGICAL COMPANY VTICMO12.6 NA

Patients

Seq Age Sex Outcome Treatment
1 42 YR Male Required Intervention UNK.